跳至主要内容
临床试验/NCT02445534
NCT02445534招募中不适用

Registry of Cell Therapy in Non-Ischemic Dilated Cardiomyopathy

University Medical Centre Ljubljana1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2005年1月最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
250
试验地点
1
主要终点
Transplantation-free survival

研究概览

简要总结

Although several studies have demonstrated beneficial effects of stem cell therapy in patients with non-ischemic dilated cardiomyopathy, the long term benefits and predictors of response to therapy remain undefined. The aim of this registry is to pool long-term clinical data in patients with non-ischemic dilated cardiomyopathy undergoing autologous cell therapy in an attempt to better define predictors of response to such treatment.

详细描述

Registry will include all patients who underwent intracoronary or intramyocardial cell therapy as a part of clinical trials performed at UMC Ljubljana from January 2005 until January 2018. Patients will be followed on regular basis in a dedicated heart failure outpatient clinic, clinical data will be collected and stored in a secure central database. Data will be analyzed in periodic intervals by an independent Data monitoring board in an attempt to better define the predictors of clinical response to cell therapy in this patient population.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient inclusion criteria consisted of the following: age 18-65 years old, diagnosis of DCM according to the European Society of Cardiology position statement (9), optimal medical management for at least 6 months, left ventricular ejection fraction (LVEF) <40%, and New York Heart Association functional Class III on stable medical therapy for at least 3 months before referral.

排除标准

  • Patients with acute multi-organ failure or a history of hematologic neoplasms were not included.

结局指标

主要结局

Transplantation-free survival

时间窗: 5 years

Survival after 5 years without undergoing heart transplantation

次要结局

  • Changes in left ventricular diastolic function(5 years)
  • Changes in left ventricular ejection fraction(5 years)
  • Changes in left ventricular dimensions(5 years)
  • Changes in right ventricular function(5 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Bojan Vrtovec

Medical Director, Advanced Heart Failure and Transplantation Center

University Medical Centre Ljubljana

研究点 (1)

Loading locations...

相似试验

进行中(未招募)
1 期
Stem cell thrapy in patients with cardiomyopathia not related to ischemicheart disease: a pilot studyThe overall aim of the project is to test the feasibility and safety of allogeneic adipose-derived stromal cells (CSCC_ASC) investigational medicinal product, to improve myocardial function in patients with nonischemic dilated cardiomyopathies (NIDCM) and heart failure.
EUCTR2018-002538-19-SIRigshospitalet30
进行中(未招募)
1 期
Stem cell therapy in heart failureIschemic heart disease and heart failureMedDRA version: 19.0Level: LLTClassification code 10019279Term: Heart failureSystem Organ Class: 100000004849
EUCTR2015-002929-19-DEDepartment of Cardiology, Rigshospitalet139
进行中(未招募)
1 期
Stem cell therapy in heart failureIschemic heart disease and heart failureMedDRA version: 19.0Level: LLTClassification code 10019279Term: Heart failureSystem Organ Class: 100000004849
EUCTR2015-002929-19-DKDepartment of Cardiology, Rigshospitalet138
进行中(未招募)
1 期
Stem cell therapy in heart failureIschemic heart disease and heart failureMedDRA version: 20.0Level: LLTClassification code 10019279Term: Heart failureSystem Organ Class: 100000011680
EUCTR2015-002929-19-PLDepartment of Cardiology, Rigshospitalet139
进行中(未招募)
1 期
Stem cell therapy in heart failureIschemic heart disease and heart failureMedDRA version: 18.1Level: LLTClassification code 10019279Term: Heart failureSystem Organ Class: 100000004849
EUCTR2015-002929-19-NLDepartment of Cardiology, Rigshospitalet139